A spinal cord injury can happen to anyone at any time. In just one moment life is changed forever. Our vision is to promote recovery from spinal cord injury and ultimately work towards a cure. 


Research Showcase

Riluzole Clinical Trial for Spinal Cord Injury in Australia

Sydney and Adelaide will join an international multi-centre clinical trial using the drug Riluzole. The Phase II clinical trial, known as RISCIS will be led by Dr Ralph Stanford across sites in Australia. The Spinal Cord Injury Network funded a feasibility study to conduct the trial in Australia and facilitated regular meetings to bring the sites together. It is believed riluzole may improve neurological recovery, reduce inflammation, and protect damaged neural tissue after injury.


Photo Gallery

Spinal Cord Injury Network Research Showcase

Highlights from the Spinal Cord Injury Network Research Showcase at the NSW Trade & Investment Centre, MLC Centre, Martin Place, in Sydney on 21 April, 2015.



Latest News

Sydney is set to join an international multi-centre clinical trial using a neuroprotective drug known as riluzole. Read more

This media release was provided to the Spinal Cord Injury Network by the SpineCare Foundation. Read more

The National Trauma Research Institute (NTRI) in Melbourne has released an overview that highlights three key forums on brain and spinal cord injury, conducted in January to July 2014.  Read more

The Network is pleased to announce the winners of the 2014 Travel Grants in Memory of Rosalind Nicholson are: Read more

This story was originally published on the Hunter Medical Research Institute website at www.hmri.com.au/2014/06/exercise-best-medicine-spinal-injury-recovery/ Read more